Trademark: 79009687
Word
CENTELION
Status Date
Thursday, November 27, 2014
Registration Number
3114451
Registration Date
Tuesday, July 11, 2006
Filing Date
Friday, November 26, 2004
Published for Opposition
Tuesday, April 18, 2006
Cancellation Date
Thursday, November 27, 2014
5 pharmaceuticals used in gene and cell therapy for treating oncologic, cardiovascular, immunological, respiratory, central nervous system or psychologic disorders
42 pharmaceutical, medical and scientific research and development services for new products
44 medical care in connection with gene and cell therapies
Jun 11, 2015
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Jun 11, 2015
Death Of International Registration
Jun 6, 2014
Total Invalidation Processed By The Ib
May 13, 2014
Total Invalidation Of Reg Ext Protection Sent To Ib
May 13, 2014
Total Invalidation Of Reg Ext Protection Created
Sep 13, 2013
Cancelled Section 71
Apr 18, 2008
Final Decision Transaction Processed By Ib
Mar 16, 2007
Final Disposition Notice Sent To Ib
Mar 16, 2007
Final Disposition Processed
Mar 13, 2007
Final Disposition Notice Created, To Be Sent To Ib
Jul 11, 2006
Registered-Principal Register
Apr 18, 2006
Published For Opposition
Mar 29, 2006
Notice Of Publication
Feb 27, 2006
Law Office Publication Review Completed
Feb 24, 2006
Assigned To Lie
Feb 21, 2006
Approved For Pub - Principal Register
Feb 3, 2006
Amendment From Applicant Entered
Jan 20, 2006
Correspondence Received In Law Office
Jan 20, 2006
Paper Received
Aug 4, 2005
Refusal Processed By Ib
Jul 19, 2005
Non-Final Action Mailed - Refusal Sent To Ib
Jul 6, 2005
Non-Final Action (Ib Refusal) Prepared For Review
Jul 5, 2005
Non-Final Action Written
Jun 29, 2005
Assigned To Examiner
Apr 29, 2005
New Application Entered In Tram
Apr 28, 2005
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
